Short-term brain atrophy evolution after initiation of immunotherapy in a real-world multiple sclerosis cohort.
Ann-Kathrin NoldMatthias WittayerClaudia E WeberMichael PlattenAchim GassPhilipp EiselePublished in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2023)
We found PBVCs that are comparable to the results of previous studies, suggesting that brain atrophy, assessed on 3D MRI data sets acquired on the same 3T MRI, provides a robust MS biomarker.